drug screen (TargetMol)
Structured Review
Drug Screen, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compounds/Cell+Cycle+Compound+Library/pm42901431-305-15-20
Average 94 stars, based on 14 article reviews
Images
Related Articles
other:Article Title: Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability Article Snippet: A Drug discovery:Article Title: Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability Article Snippet: .. For drug screening, CDC1 cells were plated in 96-well plates and treated with 130 small molecules (1 μM) of the Article Title: Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability Article Snippet: MycoSensor PCR Assay Kit (Stratagene) , Agilent Technologies (Santa Clara, CA) , 302108. .. Cell Cycle Compound Library , TargetMol (Boston, MA) , Article Title: CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphoma. Article Snippet: .. Alisertib (T2241) and a Article Title: Supporting Information for Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer Article Snippet: .. The |
![Reaction schemes and LC-MS analysis of Pp UGTs reactions with diosgenin and pennogenin . ( a ) Biosynthesis of <t>trillin</t> mediated by UGT91BP2 and UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of diosgenin. ( b ) Extracted ion chromatograms (EICs) of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and diosgenin showing the formation of trillin, as compared to the authentic trillin standard. Control is the empty expression vector. ( c ) MS spectra of the enzymatic reaction products in hydrogen and sodium ion adducts compared to the fragmentation pattern of the trillin standard. The product molecular ions [M + H] + and [M +Na] + and the feature fragment ion [M + H − Glc] + with m / z 415.32 are marked. Of note, additional peaks observed in the diosgenin EIC ( m / z 415.32) for UGT703R1–3 might correspond to substrate isomeric impurities, in-source adducts, or minor non-enzymatic by-products; these peaks, which arose from the extracted ion flow of the substrate m / z , did not co-elute with the product, trillin , and therefore did not affect the interpretation of the product formation. ( d ) Biosynthesis of pennogenin 3- O -glucoside mediated by the UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of pennogenin. ( e ) EICs of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and pennogenin showing the formation of pennogenin 3- O -glucoside, compared to the control empty expression vector. ( f ) MS/MS spectra ([M + H – Glc] + and [M + H – Glc − H 2 O] + ) of the enzymatic reaction products.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_3502/pmc13123502/pmc13123502__gr2.jpg)
